U.S., Dec. 10 -- ClinicalTrials.gov registry received information related to the study (NCT07271732) titled 'Songling Xuemaikang Capsules for Cerebral Small Vessel Disease' on Sept. 27.
Brief Summary: Cerebral small vessel disease (CSVD) is a common age-related microvascular disease related to the slow accumulation of damage to small arteries, veins, and capillaries. Hypertension is a risk factor for cerebrovascular disease, and its damage to the vascular endothelium is one of the key contributing factors to the pathogenesis of CSVD. CSVD has an insidious onset, and patients may exhibit no clinical symptoms in the early stage. Common clinical manifestations of chronic CSVD include vascular dementia, depression, gait disturbance, and abnorm...